Proton pump inhibitor and histamine-2 receptor antagonist use and risk of liver cancer in two population-based studies. (2018)
Attributed to:
UK Biobank (core renewal)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/apt.14796
PubMed Identifier: 29741272
Publication URI: http://europepmc.org/abstract/MED/29741272
Type: Journal Article/Review
Volume: 48
Parent Publication: Alimentary pharmacology & therapeutics
Issue: 1
ISSN: 0269-2813